Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Technologies, Bio-Rad Laboratories, Fujifilm Life Sciences

Premium
At Pittcon this week, Agilent Technologies introduced the 1200 Series High Performance Autosampler SL plus, which the company said “typically” delivers the lowest carryover and highest precision of any autosampler on the market [see related story, this issue].
 
Carryover is as low as .004 percent and precision is typically less than .5 percent from 2 to 5 microliters and less than .7 percent from 1 to 2 microliters.
 

 
Also at Pittcon, a Bio-Rad Laboratories official said the company will be releasing the Proteon Manager Security Edition software and Proteon Installation and Qualification and Operation Qualification kit during the summer.
 
They are validation and regulatory tools “that will allow us to go to the manufacturing QC environments with the [surface plasmon resonance] device as well as meet the needs of those individuals in clinical research who also begin to assemble their regulator tools so they can cross over into manufacturing software,” said Renee LeMaire Adkins, marketing manager for the protein function division at Bio-Rad.
 

 
Fujifilm Life Sciences this week introduced the FLA-9000 modular image scanner for radioisotopic, fluorescent, chemiluminescent, and digitized imaging. Also called Starion, the system is “ideal” for fluorescence detection of 2D gels by SYPRO Ruby stain and digitization of CBB-stained or silver-stained samples, the company said in a statement.
 
It comes in three models: IP for storage phosphor imaging; RGB Model for multi-spectral 2D gel imaging; and IR+IP Model for conducting near-infrared and radioisotopic imaging. It also offers five different excitation wavelengths, 473 nm, 532 nm, 635nm, 685 nm, and 785 nm, and a dynamic range of up to five orders of magnitude.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.